{
  "metadata": {
    "domain": "Treatment Planning",
    "difficulty": "Advanced",
    "questionCount": 4,
    "lastUpdated": "2025-05-06",
    "contributors": ["Luke", "Zachariah"],
    "stars": ["tp-dose-calculation-expert", "tp-optimization-expert", "tp-heterogeneity-expert", "tp-target-volume-expert"]
  },
  "contentMap": [
    "Expert Dose Calculation Analysis",
    "Advanced Optimization Strategy",
    "Complex Heterogeneity Management",
    "Expert Target Volume Definition"
  ],
  "questions": [
    {
      "id": "BOAST-TP-001",
      "type": "boast",
      "tags": {
        "domain": "TreatmentPlanning",
        "subtopic": "DoseCalculation",
        "difficulty": 3,
        "mentor": "Garcia",
        "knowledgeNode": "tp-dose-calculation-expert"
      },
      "question": "Dr. Garcia presents a challenging case: \"We have a patient with a small lung tumor adjacent to the chest wall, with significant atelectasis (collapsed lung) in the lower lobe. Which dose calculation approach would you recommend and why?\"",
      "options": [
        {
          "id": 1,
          "text": "Pencil beam for speed since treatment is urgent",
          "isCorrect": false
        },
        {
          "id": 2,
          "text": "AAA or Collapsed Cone because it balances accuracy and efficiency",
          "isCorrect": false
        },
        {
          "id": 3,
          "text": "Monte Carlo with careful attention to density corrections in the atelectasis region",
          "isCorrect": true
        }
      ],
      "feedback": {
        "correct": "Excellent reasoning! The complex interface between tumor, collapsed lung, and chest wall requires our most accurate algorithm, with special attention to those density variations.",
        "incorrect": "This complex case requires more careful consideration of tissue interfaces and density variations."
      }
    },
    {
      "id": "BOAST-TP-002",
      "type": "boast",
      "tags": {
        "domain": "TreatmentPlanning",
        "subtopic": "Optimization",
        "difficulty": 3,
        "mentor": "Garcia",
        "knowledgeNode": "tp-optimization-expert"
      },
      "question": "Dr. Garcia pulls up a complex case: \"This patient has bilateral hip replacements and needs prostate treatment. Given the severe artifacts and beam limitations, how would you approach the optimization problem mathematically?\"",
      "options": [
        {
          "id": 1,
          "text": "Use non-coplanar beam arrangements with angle optimization to avoid implants completely.",
          "isCorrect": true
        },
        {
          "id": 2,
          "text": "Create robust optimization with density overrides and increased OAR constraints around implant artifacts.",
          "isCorrect": false
        },
        {
          "id": 3,
          "text": "Standard VMAT techniques with manual aperture adjustment around high-density regions works best.",
          "isCorrect": false
        }
      ],
      "feedback": {
        "correct": "Outstanding approach! You've applied robust optimization principles that account for both density and positional uncertainties. This mathematical framework can provide a solution that is resilient to the inherent data uncertainties while maintaining target coverage.",
        "incorrect": "The mathematical approach to handling fundamental uncertainties in the optimization problem requires more sophisticated techniques than standard avoidance. Let's reconsider how we can build uncertainty handling directly into the optimization model."
      }
    },
    {
      "id": "BOAST-TP-003",
      "type": "boast",
      "tags": {
        "domain": "TreatmentPlanning",
        "subtopic": "Heterogeneity",
        "difficulty": 3,
        "mentor": "Kapoor",
        "knowledgeNode": "tp-heterogeneity-expert"
      },
      "question": "Dr. Kapoor presents a dose profile: \"This graph shows the dose at the interface between lung and chest wall for a small field. Explain the physical processes causing this distinctive dose distribution and how different dose calculation algorithms would model it.\"",
      "options": [
        {
          "id": 1,
          "text": "Lateral electron disequilibrium at interfaces causes dose enhancement from scattered electrons.",
          "isCorrect": false
        },
        {
          "id": 2,
          "text": "The peak comes from density changes affecting secondary electron production at the interface.",
          "isCorrect": true
        },
        {
          "id": 3,
          "text": "Beam hardening at the interface creates higher energy deposition and increased local dose.",
          "isCorrect": false
        }
      ],
      "feedback": {
        "correct": "Exceptional analysis! You've precisely identified the complex electron transport phenomena at tissue interfaces and correctly distinguished how different algorithm classes handle secondary electron modeling - the key to accurately predicting dose at these critical boundaries.",
        "incorrect": "The physics of this interface effect involves complex electron transport phenomena that different algorithm classes handle with varying levels of sophistication. This requires a deeper understanding of how secondary electrons behave at density interfaces."
      }
    },
    {
      "id": "BOAST-TP-004",
      "type": "boast",
      "tags": {
        "domain": "TreatmentPlanning",
        "subtopic": "TargetVolume",
        "difficulty": 3,
        "mentor": "Garcia",
        "knowledgeNode": "tp-target-volume-expert"
      },
      "question": "Dr. Garcia presents a challenging case: \"This patient has a locally advanced cervical cancer with bilateral pelvic and para-aortic lymph node involvement. Explain your approach to target volume definition, including how you would address the different patterns of microscopic spread and motion management.\"",
      "options": [
        {
          "id": 1,
          "text": "I would define separate CTVs: CTV-Primary (including the cervix, uterus, parametria, upper vagina with customized margins based on T-stage), CTV-Nodes (including involved nodes with 5-10mm margins), and CTV-Elective (following standardized nodal contouring atlases). For the primary CTV, I would use anisotropic ITV margins based on organ-specific motion patterns assessed with cine-MRI. The nodal regions would receive standard setup margins as they demonstrate less internal motion",
          "isCorrect": true
        },
        {
          "id": 2,
          "text": "I would create one large CTV encompassing all visible disease and use standard 1cm expansions for PTV to simplify treatment",
          "isCorrect": false
        },
        {
          "id": 3,
          "text": "I would use ICRU standard margins of 5mm for CTV and additional 5mm for PTV uniformly across all targets",
          "isCorrect": false
        }
      ],
      "feedback": {
        "correct": "Exceptional approach! You've demonstrated thorough understanding of the complex patterns of disease spread in gynecologic malignancies, with appropriate consideration of the different motion characteristics of the primary disease versus nodal regions. This nuanced approach optimizes coverage while sparing normal tissues.",
        "incorrect": "Target definition for complex gynecologic malignancies requires careful consideration of different anatomical regions with their unique patterns of microscopic spread and motion characteristics. A more tailored approach is necessary."
      }
    }
  ]
}